Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Cherrington Julie M, Director. Insider active across 2 companies, notably Mirati Therapeutics, Inc.. In total, 7 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €256k. Activity tracked since 14 January 2022. The latest transaction was disclosed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Julie M Cherrington is a Board Member at Mirati Therapeutics, Inc. She contributes to the governance of the company, bringing her expertise to strategic decision-making. Her experience in the biopharmaceutical sector is valuable in guiding development and innovation initiatives. She plays a key role in overseeing the company's operations and performance.